Scientists Revive the Dire Wolf, or Something Close - The New York Times


Colossal Biosciences has successfully created wolves with dire wolf traits through gene editing, marking a significant advancement in de-extinction technology.
AI Summary available — skim the key points instantly. Show AI Generated Summary
Show AI Generated Summary

For more than a decade, scientists have chased the idea of reviving extinct species, a process sometimes called de-extinction. Now, a company called Colossal Biosciences appears to have done it, or something close, with the dire wolf, a giant, extinct species made famous by the television series “Game of Thrones.”

In 2021, a separate team of scientists managed to retrieve DNA from the fossils of dire wolves, which went extinct about 13,000 years ago. With the discovery of additional DNA, the Colossal researchers have now edited 20 genes of gray wolves to imbue the animals with key features of dire wolves. They then created embryos from the edited gray-wolf cells, implanted them in surrogate dog mothers and waited for them to give birth.

The result is three healthy wolves — two males that are 6 months old and one female that is 2 months old, named Romulus, Remus and Khaleesi — that have some traits of dire wolves.

They are big, for one thing, and have dense, pale coats not found in gray wolves. Colossal, which was valued at $10 billion in January, is keeping the wolves on a private 2,000-acre facility at an undisclosed location in the northern United States.

Beth Shapiro, the chief scientific officer of Colossal, described the wolf pups as the first successful case of de-extinction. “We’re creating these functional copies of something that used to be alive,” she said in an interview.

The animals will remain in captivity. But the technology that the company has developed could potentially help conserve species that have not yet gone extinct, such as the critically endangered red wolf, which is largely limited to North Carolina.

We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.

Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.

Was this article displayed correctly? Not happy with what you see?

Tabs Reminder: Tabs piling up in your browser? Set a reminder for them, close them and get notified at the right time.

Try our Chrome extension today!


Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more

Facebook

Save articles to reading lists
and access them on any device


Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more

Facebook

Save articles to reading lists
and access them on any device